Spots Global Cancer Trial Database for ureter cancer

Every month we try and update this database with for ureter cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers	NCT01846520	Healthy Subject Localized Trans... Metastatic Tran... Psychosocial Ef... Recurrent Bladd... Recurrent Cervi... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Renal... Recurrent Trans... Recurrent Ureth... Recurrent Uteri... Regional Transi... Stage II Bladde... Stage II Renal ... Stage II Urethr... Stage IIA Cervi... Stage IIA Colon... Stage IIA Gastr... Stage IIA Ovari... Stage IIA Ovari... Stage IIA Pancr... Stage IIA Recta... Stage IIA Uteri... Stage IIB Cervi... Stage IIB Colon... Stage IIB Gastr... Stage IIB Ovari... Stage IIB Ovari... Stage IIB Pancr... Stage IIB Recta... Stage IIB Uteri... Stage IIC Colon... Stage IIC Ovari... Stage IIC Ovari... Stage IIC Recta... Stage III Bladd... Stage III Pancr... Stage III Renal... Stage III Ureth... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Gast... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Rect... Stage IIIA Uter... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Gast... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Rect... Stage IIIB Uter... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Rect... Stage IIIC Uter... Stage IV Bladde... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Renal ... Stage IV Urethr... Stage IVA Cervi... Stage IVA Colon... Stage IVA Recta... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Colon... Stage IVB Recta... Stage IVB Uteri... Ureter Cancer Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... Stage IIIB Lung...	educational int... telephone-based... quality-of-life... questionnaire a...	18 Years -	City of Hope Medical Center
Urine DNA Methylation Detection for Hematuria Evaluation	NCT06427993	Hematuria Urothelial Carc... Bladder Cancer Ureter Cancer Renal Pelvis Ca...		18 Years - 99 Years	Changhai Hospital
Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer	NCT01191892	Bladder Cancer Transitional Ce... Ureter Cancer Urethral Cancer	carboplatin gemcitabine hyd... vandetanib Placebo	18 Years - 120 Years	Cardiff University
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma	NCT03291028	Renal Cell Carc... Urothelial Carc... Bladder Cancer Ureter Cancer Urethral Cancer	Immune checkpoi...	-	Fox Chase Cancer Center
Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer	NCT02300610	Bladder Cancer Carcinoma, Tran... Renal Pelvis Ca... Ureter Cancer Urethra Cancer	Enzalutamide Cisplatin Gemcitabine	18 Years -	H. Lee Moffitt Cancer Center and Research Institute
Study of Genexol-PM in Patients With Advanced Urothelial Cancer Previously Treated With Gemcitabine and Platinum	NCT01426126	Bladder Cancer Ureter Cancer	Genexol PM	18 Years -	Asan Medical Center
A Genotype-Phenotype Urothelial Cancer Registry	NCT00902590	Urothelial Canc... Renal Pelvis Ca... Ureter Cancer Bladder Cancer	saliva sample a... saliva sample, ...	18 Years -	Memorial Sloan Kettering Cancer Center
Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors	NCT01352962	Urethral Neopla... Neoplasms, Uret... Cancer of the U... Urethral Cancer	Gemcitabine Carboplatin Lenalidomide	18 Years -	National Institutes of Health Clinical Center (CC)
A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer	NCT00661609	Bladder Cancer Transitional Ce... Urethra Cancer Ureter Cancer Renal Pelvis Ca...	AZD4877	18 Years -	AstraZeneca
A Genotype-Phenotype Urothelial Cancer Registry	NCT00902590	Urothelial Canc... Renal Pelvis Ca... Ureter Cancer Bladder Cancer	saliva sample a... saliva sample, ...	18 Years -	Memorial Sloan Kettering Cancer Center
Afatinib in Advanced Refractory Urothelial Cancer	NCT02122172	Distal Urethral... Proximal Urethr... Recurrent Bladd... Recurrent Ureth... Stage III Bladd... Stage III Ureth... Stage IV Bladde... Stage IV Urethr... Ureter Cancer	afatinib dimale... laboratory biom...	18 Years -	University of Chicago
Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma	NCT03296306	Bladder Cancer Ureter Cancer Urethral Cancer Transitional Ce...	Treatment durat...	18 Years -	Asan Medical Center
CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma	NCT03013920	Urinary Tract C... Urothelial Carc... Ureter Cancer		18 Years -	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy	NCT03193788	Bladder Cancer Ureter Cancer Transitional Ce...	pemetrexed Folic Acid Vitamin B12 Inj... Dexamethasone	20 Years -	Asan Medical Center
Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma	NCT03296306	Bladder Cancer Ureter Cancer Urethral Cancer Transitional Ce...	Treatment durat...	18 Years -	Asan Medical Center
Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome	NCT04625556	Urological Mali... Prostate Cancer Renal Cell Canc... Bladder Cancer Ureter Cancer		20 Years -	Yonsei University
Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract	NCT01844947	Urothelial Carc... Bladder Cancer Renal Pelvis Ca... Ureter Cancer Urethra Cancer	Vinflunine Sorafenib	18 Years - 80 Years	Karolinska University Hospital
Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors	NCT01352962	Urethral Neopla... Neoplasms, Uret... Cancer of the U... Urethral Cancer	Gemcitabine Carboplatin Lenalidomide	18 Years -	National Institutes of Health Clinical Center (CC)
Afatinib in Advanced Refractory Urothelial Cancer	NCT02122172	Distal Urethral... Proximal Urethr... Recurrent Bladd... Recurrent Ureth... Stage III Bladd... Stage III Ureth... Stage IV Bladde... Stage IV Urethr... Ureter Cancer	afatinib dimale... laboratory biom...	18 Years -	University of Chicago
Arsenic Trioxide in Treating Patients With Urothelial Cancer	NCT00009867	Recurrent Trans... Recurrent Ureth... Transitional Ce... Ureter Cancer	arsenic trioxid...	18 Years -	National Cancer Institute (NCI)
A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function	NCT02665039	Urothelial Carc... Bladder Cancer Renal Pelvis Ca... Ureter Cancer Urethra Cancer	Vinflunine Gemcitabine Carboplatin	18 Years -	Karolinska University Hospital
Arsenic Trioxide in Treating Patients With Urothelial Cancer	NCT00009867	Recurrent Trans... Recurrent Ureth... Transitional Ce... Ureter Cancer	arsenic trioxid...	18 Years -	National Cancer Institute (NCI)
A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy	NCT01234519	Urothelial Carc...	AEZS-108 AEZS-108 at MTD	18 Years -	AEterna Zentaris
A Study of LOXO-435 in Participants With Cancer With a Change in a Gene Called FGFR3	NCT05614739	Urinary Bladder... Neoplasm Metast... Ureteral Neopla...	LOXO-435 Pembrolizumab	18 Years -	Eli Lilly and Company
A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function	NCT02665039	Urothelial Carc... Bladder Cancer Renal Pelvis Ca... Ureter Cancer Urethra Cancer	Vinflunine Gemcitabine Carboplatin	18 Years -	Karolinska University Hospital
Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer	NCT02300610	Bladder Cancer Carcinoma, Tran... Renal Pelvis Ca... Ureter Cancer Urethra Cancer	Enzalutamide Cisplatin Gemcitabine	18 Years -	H. Lee Moffitt Cancer Center and Research Institute
A Study of LOXO-435 in Participants With Cancer With a Change in a Gene Called FGFR3	NCT05614739	Urinary Bladder... Neoplasm Metast... Ureteral Neopla...	LOXO-435 Pembrolizumab	18 Years -	Eli Lilly and Company
Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies	NCT01182168	Bladder Cancer Renal Pelvis Ca... Ureter Cancer	gemcitabine and...	18 Years -	Memorial Sloan Kettering Cancer Center
Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma	NCT04004442	Urothelial Carc...	Avelumab AVB-S6-500	18 Years -	University of Oklahoma
UroCAD Assay Combined With Computed Tomography Urography and Urine Cytology for UTUC Diagnosis.	NCT05043662	Urothelial Carc... Diagnoses Disea... Ureter Cancer IMAGE Cytology	UroCAD assay, C...	18 Years -	Changhai Hospital
TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma	NCT01328574	Urothelial Carc... Ureteral Neopla... Ureter Cancer Neoplasm, Urete... Cancer of the U...	TRC105	18 Years - 99 Years	National Institutes of Health Clinical Center (CC)
Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma	NCT00072150	Metastatic Tran... Recurrent Bladd... Recurrent Trans... Recurrent Ureth... Stage III Bladd... Stage III Ureth... Stage IV Bladde... Stage IV Urethr... Transitional Ce... Ureter Cancer	bortezomib	18 Years -	National Cancer Institute (NCI)
Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer	NCT01639521	Anterior Urethr... Localized Trans... Posterior Ureth... Recurrent Bladd... Recurrent Ureth... Regional Transi... Stage III Bladd... Transitional Ce... Ureter Cancer Urethral Cancer...	cisplatin gemcitabine hyd... methotrexate vinblastine doxorubicin hyd... pegfilgrastim laboratory biom...	18 Years -	University of Southern California
Integrated Cancer Repository for Cancer Research	NCT02012699	Pancreatic Canc... Thyroid Cancer Lung Cancer Esophageal Canc... Thymus Cancer Colon Cancer Rectal Cancer Gastrointestina... Anal Cancer Bile Duct Cance... Duodenal Cancer Gallbladder Can... Gastric Cancer Liver Cancer Small Intestine... Peritoneal Surf... Familial Adenom... Lynch Syndrome Bladder Cancer Kidney Cancer Penile Cancer Prostate Cancer Testicular Canc... Ureter Cancer Urethral Cancer Hypopharyngeal ... Laryngeal Cance... Lip Cancer Oral Cavity Can... Nasopharyngeal ... Oropharyngeal C... Paranasal Sinus... Nasal Cavity Ca... Salivary Gland ... Skin Cancer Central Nervous... Central Nervous... Mesothelioma Breast Cancer Leukemia Melanoma Sarcoma Unknown Primary... Multiple Myelom... Ovarian Cancer Endometrial Can... Vaginal Cancer Neuroendocrine ... Plasma Cell Dys... Healthy Control		19 Years - 110 Years	University of Nebraska
Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma	NCT00072150	Metastatic Tran... Recurrent Bladd... Recurrent Trans... Recurrent Ureth... Stage III Bladd... Stage III Ureth... Stage IV Bladde... Stage IV Urethr... Transitional Ce... Ureter Cancer	bortezomib	18 Years -	National Cancer Institute (NCI)
Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases	NCT03520231	Urothelial Carc... Kidney Cancer Ureter Cancer Bladder Cancer	Denosumab Denosumab Place... Gemcitabine Carboplatin Cisplatin Calcium Vitamin D	18 Years -	University Health Network, Toronto

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: